Bridging Data to Decisions: Real-World Evidence and Life Science Analytics Explained | 17th - 18th October 2024| Boston, USA

We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science Analytics Conference at Boston 2024, a premier gathering of thought leaders, industry experts, and innovators at the forefront of revolutionizing healthcare through data-driven insights. Set against the backdrop of advancements in real-world evidence, this conference promises an enriching experience for professionals in life sciences, healthcare, and analytics.

The 7th Annual Real-World Evidence and Life Science Analytics Conference is not just an event; it's an opportunity to be part of the conversation shaping the future of healthcare. Join us for an inspiring and collaborative experience as we explore ways to bridge insights to impact in the dynamic world of real-world evidence.

Register Now @ https://events.marketsandmarkets.com/7th-annual-marketsandmarkets-real-world-evidence-and-life-science-analytics-conference/register

Real-World Evidence (RWE):-

Real-world evidence refers to data regarding the use and potential benefits or risks of a medical product derived from real-world clinical practice. Unlike data from randomized controlled trials (RCTs), which are conducted under controlled conditions, RWE is collected from sources such as electronic health records (EHRs), claims databases, patient registries, and wearable devices.

Life Sciences Analytics:-

Life sciences analytics involves the application of data analytics, statistical analysis, and machine learning techniques to generate insights from healthcare and life sciences data. This data may include clinical trial data, real-world evidence, genomic data, patient data, and market data.

Conference Speakers-

• Megan Sutton- Senior Medical Director, Clinical Development and Real-world Evidence, Lexeo Therapeutics

• Adrian Kielhorn- Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc

• Amit Kulkarni- Head of Health Economic Modeling and Decision Sciences, Otsuka Pharmaceutical Companies

• Nancy Dreyer- Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill

• Ravi Iyer- Sr. Director,Head Real World Evidence Strategy,GHEOR, Teva Pharmaceuticals

…………….more

Become a Speaker @ https://events.marketsandmarkets.com/7th-annual-marketsandmarkets-real-world-evidence-and-life-science-analytics-conference/speaker-enquiry

Key Highlights-

• Gain insights into regulatory perspectives on data quality and standards, Integration of RWE into Clinical Trials

• Explore the strategic utilization of Real-World Evidence (RWE) to enhance market access.

• Regulatory Landscape for Medical Devices, Post-Market Surveillance and Safety Monitoring

• Uncover the expanded realm of RWE's influence on digital health, Patient-Centric Approaches in Device Research

• Examine the synergy between Real-World Data and Advanced Analytics, Economic impact evaluations using real-world evidence.

• Epidemiological Insights using Real World Evidence

Become a Sponsor @ https://events.marketsandmarkets.com/7th-annual-marketsandmarkets-real-world-evidence-and-life-science-analytics-conference/become-sponsor

ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013

About Us-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

This release was published on openPR.